Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dice Therapeutics Inc (NQ: DICE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 8, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Dice Therapeutics Inc < Previous 1 2 3 Next > Recap: DICE Therapeutics Q1 Earnings May 11, 2023 Via Benzinga Over $40M Bet On 89bio? Check Out These 3 Stocks Insiders Are Buying March 31, 2023 Although US stocks closed higher on Thursday, there were a few notable insider trades. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 March 01, 2023 Via Benzinga These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher. November 18, 2022 The good times could keep on rolling for these big winners. Via The Motley Fool Where DICE Therapeutics Stands With Analysts November 15, 2022 Via Benzinga What Is Going on With DICE Therapeutics (DICE) Stock? October 11, 2022 Shares of DICE stock are up an astounding 50% today on news of a positive clinical trial related to the Dice's psoriasis treatment. Via InvestorPlace DICE Therapeutics Stock Doubles After Positive Data From Lead Psoriasis Candidate October 11, 2022 Via Benzinga Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock November 11, 2022 One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are... Via Benzinga Around $60 Million Bet On DICE Therapeutics? 3 Stocks Insiders Are Buying October 20, 2022 Although US stocks closed lower on Wednesday, there were a few notable insider trades. Via Benzinga Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation' October 18, 2022 On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist." Via Benzinga Bear Market Hits New Lows, But Stocks Rebound After Hot CPI Inflation Report: Weekly Review October 14, 2022 The major indexes tumbled to bear market lows after a hot CPI inflation report, but then roared back. Via Investor's Business Daily Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday October 12, 2022 Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. Via Benzinga Nasdaq Drops 150 Points; AZZ Shares Plummet October 11, 2022 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 150 points on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 11, 2022 Gainers Via Benzinga Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session October 11, 2022 Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939. Via Benzinga Dow Surges Over 100 Points; Crude Oil Down 2% October 11, 2022 U.S. stocks pared some losses midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. Via Benzinga DICE Therapeutics, Amgen And Some Other Big Stocks Moving Higher On Tuesday October 11, 2022 U.S. stocks traded mostly lower, with the Nasdaq dropping more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga US Stocks Open Lower, Dow Falls 100 Points October 11, 2022 U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday. Via Benzinga Analyzing DICE Therapeutics's Short Interest October 11, 2022 DICE Therapeutics's (NASDAQ:DICE) short percent of float has fallen 5.55% since its last report. The company recently reported that it has 4.93 million shares sold short, which is 17.52% of all regular... Via Benzinga Nasdaq Bear Market: 2 Stocks Defying the Downturn October 11, 2022 One of these companies is a leader in its niche, while the other wants to become one. Via The Motley Fool Dice Therapeutics Surges To Record High As Psoriasis Pill Promises To Lead Its Class October 11, 2022 The company is testing a potential pill to treat psoriasis. Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 11, 2022 Gainers DICE Therapeutics (NASDAQ:DICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion. Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session September 22, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Looking Into DICE Therapeutics's Recent Short Interest September 13, 2022 DICE Therapeutics's (NASDAQ:DICE) short percent of float has fallen 7.8% since its last report. The company recently reported that it has 5.22 million shares sold short, which... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session September 12, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022 September 14, 2022 Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low... Via Benzinga Dow Up Over 280 Points, Fourth-Straight Win In Sight September 12, 2022 Stocks are firmly higher midday, with the Dow Jones Industrial Average last seen up over 280 points, while both the S&P 500 Index and Nasdaq Composite boast sizable gains of their own. Via Talk Markets Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday September 13, 2022 Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. Via Benzinga Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session September 12, 2022 Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. Via Benzinga Livent, Amgen And Some Other Big Stocks Moving Lower On Monday September 12, 2022 U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.